Theriva Biologics Faces Delays in Warrant Approval Meeting

An update from Theriva Biologics ( (TOVX) ) is now available.

On April 9, 2026, Theriva Biologics was unable to convene a Special Meeting of Stockholders because an insufficient number of common shares were present or represented by proxy to constitute a quorum, preventing a vote on proposals tied to warrant exercises and meeting adjournment. The company will call a new stockholder meeting and, under its October 16, 2025 warrant inducement agreement with institutional investors, must continue scheduling meetings roughly every 60 days to seek approval for issuing up to 16,184,560 shares upon exercise of new warrants, unless investors waive this requirement or the warrants expire, creating ongoing procedural and timing uncertainty around its planned equity issuance and related financing strategy.

The most recent analyst rating on (TOVX) stock is a Sell with a $0.28 price target. To see the full list of analyst forecasts on Theriva Biologics stock, see the TOVX Stock Forecast page.

Spark’s Take on TOVX Stock

According to Spark, TipRanks’ AI Analyst, TOVX is a Neutral.

The score is held down primarily by weak financial performance (no revenue, ongoing losses, and sustained cash burn). Technicals provide some near-term support with bullish momentum, while corporate events are mixed (Phase 3 regulatory alignment positive, warrant-approval delay negative) and valuation support is limited due to negative earnings and no dividend.

To see Spark’s full report on TOVX stock, click here.

More about Theriva Biologics

Theriva Biologics, Inc. is a biotechnology company focused on developing therapeutic products, with its capital structure including common stock and common stock purchase warrants held by institutional investors. The company engages in securities transactions such as warrant inducement agreements that require shareholder approval for the issuance of additional common shares upon warrant exercise, underscoring its reliance on equity financing to support operations and growth initiatives.

Average Trading Volume: 12,594,848

Technical Sentiment Signal: Sell

Current Market Cap: $13.63M

See more insights into TOVX stock on TipRanks’ Stock Analysis page.